1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Saudek, V.
Pastore, A.
Ramponi, G.
Williams, R.J.P.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
224
427
440
10.1016/0022-2836(92)91005-A
1313885
Three-dimensional structure of acylphosphatase. Refinement and structure analysis.
1992
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
207
405
Identification and Description of Beta-Structure in Horse Muscle Acylphosphatase by Nuclear Magnetic Resonance Spectroscopy
1989
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
205
229
Identification and Description of Alpha-Helical Regions in Horse Muscle Acylphosphatase by 1H Nuclear Magnetic Resonance Spectroscopy
1989
10.2210/pdb1aps/pdb
pdb_00001aps
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
11032.437
ACYLPHOSPHATASE
3.6.1.7
1
man
polymer
no
no
STARPLKSVDYEVFGRVQGVCFRMYAEDEARKIGVVGWVKNTSKGTVTGQVQGPEEKVNSMKSWLSKVGSPSSRIDRTNF
SNEKTISKLEYSNFSVRY
STARPLKSVDYEVFGRVQGVCFRMYAEDEARKIGVVGWVKNTSKGTVTGQVQGPEEKVNSMKSWLSKVGSPSSRIDRTNF
SNEKTISKLEYSNFSVRY
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
horse
Equus
sample
9796
Equus caballus
database_2
pdbx_database_status
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
Other
1
0
1992-07-15
1
1
2008-03-24
1
2
2011-07-13
1
3
2022-02-16
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.process_site
Y
BNL
1991-02-20
REL
REL
5
SER
1
n
1
SER
1
A
THR
2
n
2
THR
2
A
ALA
3
n
3
ALA
3
A
ARG
4
n
4
ARG
4
A
PRO
5
n
5
PRO
5
A
LEU
6
n
6
LEU
6
A
LYS
7
n
7
LYS
7
A
SER
8
n
8
SER
8
A
VAL
9
n
9
VAL
9
A
ASP
10
n
10
ASP
10
A
TYR
11
n
11
TYR
11
A
GLU
12
n
12
GLU
12
A
VAL
13
n
13
VAL
13
A
PHE
14
n
14
PHE
14
A
GLY
15
n
15
GLY
15
A
ARG
16
n
16
ARG
16
A
VAL
17
n
17
VAL
17
A
GLN
18
n
18
GLN
18
A
GLY
19
n
19
GLY
19
A
VAL
20
n
20
VAL
20
A
CYS
21
n
21
CYS
21
A
PHE
22
n
22
PHE
22
A
ARG
23
n
23
ARG
23
A
MET
24
n
24
MET
24
A
TYR
25
n
25
TYR
25
A
ALA
26
n
26
ALA
26
A
GLU
27
n
27
GLU
27
A
ASP
28
n
28
ASP
28
A
GLU
29
n
29
GLU
29
A
ALA
30
n
30
ALA
30
A
ARG
31
n
31
ARG
31
A
LYS
32
n
32
LYS
32
A
ILE
33
n
33
ILE
33
A
GLY
34
n
34
GLY
34
A
VAL
35
n
35
VAL
35
A
VAL
36
n
36
VAL
36
A
GLY
37
n
37
GLY
37
A
TRP
38
n
38
TRP
38
A
VAL
39
n
39
VAL
39
A
LYS
40
n
40
LYS
40
A
ASN
41
n
41
ASN
41
A
THR
42
n
42
THR
42
A
SER
43
n
43
SER
43
A
LYS
44
n
44
LYS
44
A
GLY
45
n
45
GLY
45
A
THR
46
n
46
THR
46
A
VAL
47
n
47
VAL
47
A
THR
48
n
48
THR
48
A
GLY
49
n
49
GLY
49
A
GLN
50
n
50
GLN
50
A
VAL
51
n
51
VAL
51
A
GLN
52
n
52
GLN
52
A
GLY
53
n
53
GLY
53
A
PRO
54
n
54
PRO
54
A
GLU
55
n
55
GLU
55
A
GLU
56
n
56
GLU
56
A
LYS
57
n
57
LYS
57
A
VAL
58
n
58
VAL
58
A
ASN
59
n
59
ASN
59
A
SER
60
n
60
SER
60
A
MET
61
n
61
MET
61
A
LYS
62
n
62
LYS
62
A
SER
63
n
63
SER
63
A
TRP
64
n
64
TRP
64
A
LEU
65
n
65
LEU
65
A
SER
66
n
66
SER
66
A
LYS
67
n
67
LYS
67
A
VAL
68
n
68
VAL
68
A
GLY
69
n
69
GLY
69
A
SER
70
n
70
SER
70
A
PRO
71
n
71
PRO
71
A
SER
72
n
72
SER
72
A
SER
73
n
73
SER
73
A
ARG
74
n
74
ARG
74
A
ILE
75
n
75
ILE
75
A
ASP
76
n
76
ASP
76
A
ARG
77
n
77
ARG
77
A
THR
78
n
78
THR
78
A
ASN
79
n
79
ASN
79
A
PHE
80
n
80
PHE
80
A
SER
81
n
81
SER
81
A
ASN
82
n
82
ASN
82
A
GLU
83
n
83
GLU
83
A
LYS
84
n
84
LYS
84
A
THR
85
n
85
THR
85
A
ILE
86
n
86
ILE
86
A
SER
87
n
87
SER
87
A
LYS
88
n
88
LYS
88
A
LEU
89
n
89
LEU
89
A
GLU
90
n
90
GLU
90
A
TYR
91
n
91
TYR
91
A
SER
92
n
92
SER
92
A
ASN
93
n
93
ASN
93
A
PHE
94
n
94
PHE
94
A
SER
95
n
95
SER
95
A
VAL
96
n
96
VAL
96
A
ARG
97
n
97
ARG
97
A
TYR
98
n
98
TYR
98
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
CYS
21
10.60
1
A
ASN
93
10.99
2
A
PRO
54
10.48
2
A
GLU
55
10.43
2
A
ILE
75
10.78
3
A
VAL
36
11.25
5
A
ALA
26
-10.51
5
A
VAL
47
10.11
1
A
TYR
98
0.109
SIDE CHAIN
2
A
TYR
11
0.066
SIDE CHAIN
2
A
TYR
25
0.078
SIDE CHAIN
2
A
ARG
74
0.103
SIDE CHAIN
3
A
TYR
11
0.081
SIDE CHAIN
3
A
PHE
94
0.085
SIDE CHAIN
4
A
TYR
11
0.145
SIDE CHAIN
4
A
PHE
22
0.080
SIDE CHAIN
5
A
TYR
11
0.121
SIDE CHAIN
5
A
TYR
25
0.133
SIDE CHAIN
1
3.02
0.50
120.30
123.32
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
4
4
4
N
1
-4.42
0.60
121.00
116.58
A
A
A
CB
CG
CD2
TYR
TYR
TYR
98
98
98
N
2
-3.99
0.60
121.00
117.01
A
A
A
CB
CG
CD1
TYR
TYR
TYR
25
25
25
N
2
-3.91
0.60
121.00
117.09
A
A
A
CB
CG
CD2
TYR
TYR
TYR
91
91
91
N
3
-3.78
0.60
121.00
117.22
A
A
A
CB
CG
CD2
TYR
TYR
TYR
25
25
25
N
3
-4.79
0.60
121.00
116.21
A
A
A
CB
CG
CD2
TYR
TYR
TYR
91
91
91
N
4
-3.71
0.60
121.00
117.29
A
A
A
CB
CG
CD2
TYR
TYR
TYR
11
11
11
N
4
3.23
0.50
120.30
123.53
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
16
16
16
N
4
-4.39
0.60
121.00
116.61
A
A
A
CB
CG
CD2
TYR
TYR
TYR
25
25
25
N
5
3.07
0.50
120.30
123.37
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
4
4
4
N
5
-3.66
0.60
121.00
117.34
A
A
A
CB
CG
CD1
TYR
TYR
TYR
25
25
25
N
1
A
GLN
18
53.33
-139.14
1
A
VAL
20
-54.13
99.91
1
A
MET
24
63.90
-57.19
1
A
THR
46
-64.83
83.52
1
A
THR
48
-102.61
-169.52
1
A
LEU
65
71.01
-36.74
1
A
LYS
67
-61.73
99.64
1
A
SER
72
-178.66
-68.55
1
A
ARG
77
68.39
112.87
1
A
ASN
82
69.44
90.35
1
A
ILE
86
-126.07
-159.93
1
A
LYS
88
59.01
157.34
1
A
GLU
90
-83.04
34.55
1
A
ASN
93
59.83
176.66
1
A
SER
95
-108.70
-139.53
2
A
THR
2
59.75
-43.82
2
A
ALA
3
69.41
-36.83
2
A
LEU
6
-166.64
38.49
2
A
LYS
7
-104.37
79.51
2
A
ARG
16
-98.64
-79.82
2
A
VAL
20
-27.91
-71.77
2
A
CYS
21
64.44
-27.54
2
A
PHE
22
-63.97
20.51
2
A
ARG
23
-62.86
-73.38
2
A
THR
42
-77.76
37.22
2
A
SER
43
65.00
-50.99
2
A
PRO
54
-61.30
86.85
2
A
GLU
56
55.53
-88.87
2
A
SER
72
67.85
124.04
2
A
ASP
76
-134.74
-48.79
2
A
SER
81
-120.61
-165.70
2
A
ASN
82
47.67
74.06
2
A
LEU
89
-67.38
76.94
2
A
GLU
90
-96.34
59.29
2
A
TYR
91
179.50
131.27
2
A
ASN
93
-174.85
134.70
2
A
ARG
97
-59.63
104.50
3
A
THR
2
-75.42
46.57
3
A
ALA
3
54.91
-51.92
3
A
GLN
18
71.84
-30.86
3
A
CYS
21
-149.04
-85.56
3
A
PHE
22
58.14
-46.91
3
A
ARG
23
-12.05
-81.11
3
A
VAL
36
65.15
152.16
3
A
THR
46
-61.16
79.97
3
A
PRO
54
-15.18
82.61
3
A
GLU
56
57.91
-88.29
3
A
SER
70
-128.28
-74.68
3
A
PRO
71
-44.12
102.39
3
A
SER
73
-155.38
-66.35
3
A
ARG
74
68.40
-61.52
3
A
ILE
75
32.05
110.57
3
A
ARG
77
-163.49
110.71
3
A
ASN
79
-68.24
98.92
3
A
SER
81
-92.67
-69.17
3
A
LYS
88
98.55
149.05
3
A
VAL
96
48.39
-178.93
4
A
PRO
5
-76.71
33.62
4
A
GLN
18
52.68
-110.89
4
A
CYS
21
-101.43
64.98
4
A
GLU
27
-73.28
-83.42
4
A
THR
48
-109.77
-164.26
4
A
GLU
55
-17.83
-61.87
4
A
SER
66
-101.64
-109.23
4
A
LYS
67
-110.22
75.61
4
A
VAL
68
-128.09
-52.10
4
A
SER
72
-131.19
-43.83
4
A
ARG
74
-69.84
86.37
4
A
ASN
82
53.82
84.89
4
A
LYS
88
61.56
149.90
4
A
TYR
91
154.19
150.91
4
A
ASN
93
61.42
172.14
4
A
VAL
96
54.95
163.62
5
A
THR
2
-133.74
-82.13
5
A
ALA
3
-122.63
-139.54
5
A
PRO
5
-68.14
72.80
5
A
VAL
20
66.98
-72.44
5
A
ARG
23
-21.03
-73.82
5
A
THR
42
-104.00
-130.17
5
A
LYS
44
49.76
85.91
5
A
VAL
68
62.01
-70.02
5
A
PRO
71
-56.95
109.93
5
A
ARG
74
74.10
-33.04
5
A
ILE
75
58.37
-84.19
5
A
ASP
76
57.76
-41.37
5
A
PHE
80
-72.27
37.80
5
A
LYS
88
73.08
156.32
5
A
ARG
97
-6.63
123.67
THREE-DIMENSIONAL STRUCTURE OF ACYLPHOSPHATASE. REFINEMENT AND STRUCTURE ANALYSIS
1
Y
N
A
PHE
22
A
PHE
22
HELX_P
A
ILE
33
A
ILE
33
1
H1
12
A
GLU
55
A
GLU
55
HELX_P
A
LEU
65
A
LEU
65
1
H2
11
HYDROLASE(ACTING ON ACID ANHYDRIDES)
HYDROLASE(ACTING ON ACID ANHYDRIDES)
A
SER
70
A
SER
70
4
A
PRO
71
A
PRO
71
-10.83
ACYP2_HORSE
UNP
1
1
P00818
STARPLKSVDYEVFGRVQGVCFRMYAEDEARKIGVVGWVKNTSKGTVTGQVQGPEEKVNSMKSWLSKVGSPSSRIDRTNF
SNEKTISKLEYSNFSVRY
1
98
1APS
1
98
P00818
A
1
1
98
5
parallel
anti-parallel
parallel
anti-parallel
A
LYS
7
A
LYS
7
A
VAL
13
A
VAL
13
A
VAL
36
A
VAL
36
A
THR
42
A
THR
42
A
THR
46
A
THR
46
A
GLY
53
A
GLY
53
A
ARG
77
A
ARG
77
A
THR
85
A
THR
85
A
ASN
93
A
ASN
93
A
ARG
97
A
ARG
97
1
P 1